EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development and experimental validation of an M2 macrophage and platelet‐associated gene signature to predict prognosis and immunotherapy sensitivity in bladder cancer

Bahaerguli Muhuitijiang, Jiawei Zhou, Ranran Zhou, Zhiyong Zhang iD, Guang Yan, Zaosong Zheng, Xiangbo Zeng, Yuanchao Zhu, Haowei Wu, Ruxi Gao, Tianhang Zhu, Xiaojun Shi und 1 weitere

Cancer Science · 2024-05 · 115 (5) · 1417-1432

DOI: 10.1111/cas.16113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, online erschienen am 29.02.2024. Verfasst von Bahaerguli Muhuitijiang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Blood Platelets, Immunotherapy, Macrophages, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Guangzhou Municipal Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platelets and M2 macrophages both play crucial roles in tumorigenesis, but their relationship and the prognosis value of the relative genes in bladder cancer (BLCA) remain obscure. In the present study, we found that platelets stimulated by BLCA cell lines could promote M2 macrophage polarization, and platelets were significantly associated with the infiltration of M2 macrophages in BLCA samples. Through the bioinformatic analyses, A2M , TGFB3 , and MYLK , which were associated with platelets and M2 macrophages, were identified and verified in vitro and then included in the predictive model. A platelet and M2 macrophage‐related gene signature was constructed to evaluate the prognosis and immunotherapeutic sensitivity, helping to guide personalized treatment and to disclose the underlying mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PlateletsImmunotherapyMacrophagesUrinary Bladder NeoplasmsFemaleHumansMaleMiddle AgedCell Line, TumorComputational BiologyGene Expression ProfilingGene Expression Regulation, NeoplasticPrognosisTranscriptome

Stichwörter der Autor:innen

M2 macrophagebladder cancerimmunotherapyplateletprognosis

Autor:innen und Institutionen

  • Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • The First Clinical Medical College of Southern Medical University, Guangzhou, Guangdong, China.

ORCID-Profile: Zhiyong Zhang, Wanlong Tan

Förderung

  • National Natural Science Foundation of China
  • Guangzhou Municipal Science and Technology Project

Zitieren

APA

Muhuitijiang, B., Zhou, J., Zhou, R., Zhang, Z., Yan, G., Zheng, Z., Zeng, X., Zhu, Y., Wu, H., Gao, R., Zhu, T., Shi, X., & Tan, W. (2024). Development and experimental validation of an M2 macrophage and platelet‐associated gene signature to predict prognosis and immunotherapy sensitivity in bladder cancer. Cancer Science, 115(5), 1417-1432. https://doi.org/10.1111/cas.16113

Vancouver

Muhuitijiang B, Zhou J, Zhou R, Zhang Z, Yan G, Zheng Z, et al. Development and experimental validation of an M2 macrophage and platelet‐associated gene signature to predict prognosis and immunotherapy sensitivity in bladder cancer. Cancer Science. 2024;115(5):1417-1432. doi:10.1111/cas.16113

BibTeX
@article{Muhuitijiang2024,
  author = {Muhuitijiang, Bahaerguli and Zhou, Jiawei and Zhou, Ranran and Zhang, Zhiyong and Yan, Guang and Zheng, Zaosong and Zeng, Xiangbo and Zhu, Yuanchao and Wu, Haowei and Gao, Ruxi and Zhu, Tianhang and Shi, Xiaojun and Tan, Wanlong},
  title = {Development and experimental validation of an M2 macrophage and platelet‐associated gene signature to predict prognosis and immunotherapy sensitivity in bladder cancer},
  journal = {Cancer Science},
  year = {2024},
  volume = {115},
  number = {5},
  pages = {1417--1432},
  doi = {10.1111/cas.16113}
}
Kostenlos starten →